Stay updated on Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.6.5 has been added, replacing the previous revision tag v3.6.4. This indicates an update to the page's version of the content or template.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor maintenance update to the study record page. It signals internal improvements or bug fixes and does not alter the study data or visible content.SummaryDifference0.0%

- Check37 days agoChange DetectedA new publication citation is added to the Publications section, listing Earley et al. Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials (CNS Drugs, 2026 Jul 15; Online ahead of print).SummaryDifference0.0%

- Check51 days agoChange DetectedA new revision label, v3.6.3, was introduced, replacing the previous v3.6.2. This represents a minor update to the page's revision history and does not modify visible content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating a backend/content-management update. The visible study details appear unchanged.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded sections How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading; the Intervention / Treatment heading was changed to Intervention/Treatment, and the revision tag updated to v3.6.0 with a recruitment note indicating no participants are being sought.SummaryDifference0.3%

Stay in the know with updates to Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial page.